Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FengLing vs FengLing+ vs sodium bicarbonate in primary gout with hyperuricemia
ChiCTR2100050749Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of FengLing, sodium bicarbonate and febuxostat in gout and hyperuricemia (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Serum uric acid and Urinary pH. Started Sep 2021; status: recruiting.
02
Drugs
FengLingsodium bicarbonatefebuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR2100050749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050749.